These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26329150)

  • 1. [Fabry Disease: Pathogenesis, Clinical Symptoms, and Treatment with Enzyme Replacement Therapy].
    Sawai S
    Brain Nerve; 2015 Sep; 67(9):1099-108. PubMed ID: 26329150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous complications of Anderson-Fabry disease.
    Giuseppe P; Daniele R; Rita BM
    Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
    Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
    CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry disease: treatment and diagnosis.
    Rozenfeld PA
    IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts.
    Spada M; Baron R; Elliott PM; Falissard B; Hilz MJ; Monserrat L; Tøndel C; Tylki-Szymańska A; Wanner C; Germain DP
    Mol Genet Metab; 2019 Mar; 126(3):212-223. PubMed ID: 29785937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.
    Furujo M; Kubo T; Kobayashi M; Ohashi T
    Mol Genet Metab; 2013 Nov; 110(3):405-10. PubMed ID: 23906479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fabry disease].
    Subran B; Montagner C; London J; Lidove O; Mauhin W
    Rev Prat; 2020 May; 70(5):537-540. PubMed ID: 33058644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anderson-Fabry disease: developments in diagnosis and treatment.
    Mehta AB
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S66-74. PubMed ID: 20040315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal complications of Fabry disease.
    Basic-Jukic N; Kes P; Coric M; Basic-Kes V
    Curr Pharm Des; 2013; 19(33):6046-50. PubMed ID: 23448456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroenterological complications of Anderson-Fabry disease.
    Buda P; Książyk J; Tylki-Szymanska A
    Curr Pharm Des; 2013; 19(33):6009-13. PubMed ID: 23448457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and Gene Therapy of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
    Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes.
    Kim JH; Lee BH; Hyang Cho J; Kang E; Choi JH; Kim GH; Yoo HW
    J Hum Genet; 2016 Nov; 61(11):923-929. PubMed ID: 27334365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued.
    Politei J
    Mol Genet Metab; 2020 Aug; 130(4):227-229. PubMed ID: 32561366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.
    Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI
    Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry's disease.
    Zarate YA; Hopkin RJ
    Lancet; 2008 Oct; 372(9647):1427-35. PubMed ID: 18940466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of fabry disease: current and emerging strategies.
    Rozenfeld P; Neumann PM
    Curr Pharm Biotechnol; 2011 Jun; 12(6):916-22. PubMed ID: 21235448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffuse hyperkeratotic papules of the lower abdomen and genital region in a 38-year old male patient].
    Kuntz T; Mitrakos G; Koushk-Jalali B; Oellig F; Eismann L; Tigges C; Kreuter A
    Internist (Berl); 2020 Jun; 61(6):621-625. PubMed ID: 32367302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The neurological manifestations of Fabry disease. A review].
    Firsov KV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.